Thaci D, Gottlieb A, Reich K, Bagel J, Burge D, Peterson L, Drew J, Arendt C, Weglowska J. Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). J of Skin [Internet]. 2017Oct.27 [cited 2022May16];1(3.1):s4. Available from: https://www.jofskin.org/index.php/skin/article/view/126